Friday, October 15, 2010

Medtronics settles claims for device linked to 13 deaths

Bloomberg reports that Medtronic has agreed to pay $268 million to settle claims resulting from allegedly defective heart defibrulator components.  The company, which is the world's largest manufacturer of such devices, stopped sales of certain wire leads that were used in its Sprint Fidelis devices in 2007 after reports surfaced of possible defects in construction.  In 2009, the company acknowledged that the wires "may have been a possible or likely contributing factor" in 13 deaths.

Turkheimer & Hadden, LLC
Attorneys at Law
(404) 890-7200

No comments:

Post a Comment